Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Parasitol Res ; 112(11): 3859-63, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23949312

RESUMO

Fusidic acid is a bacteriostatic antibiotic that inhibits the growth of bacteria by preventing the release of translation elongation factor G (EF-G) from the ribosome. The apicomplexan parasite Toxoplasma gondii has an orthologue of bacterial EF-G that can complement bacteria and is necessary for parasite virulence. Fusidic acid has been shown to be effective in tissue culture against the related pathogen Plasmodium falciparum, and current drug treatments against T. gondii are limited. We therefore investigated the therapeutic value of fusidic acid for T. gondii and found that the drug was effective in tissue culture, but not in a mouse model of infection. To determine whether this trend would occur in another intracellular pathogen that elicits a T helper 1-type immune response, we tested the efficacy of fusidic acid for the bacterium Listeria monocytogenes. Similar to its effects on T. gondii, fusidic acid inhibits the growth of L. monocytogenes in vitro, but not in mice. These findings highlight the necessity of in vivo follow-up studies to validate in vitro drug investigations.


Assuntos
Anti-Infecciosos/farmacologia , Anti-Infecciosos/uso terapêutico , Ácido Fusídico/farmacologia , Ácido Fusídico/uso terapêutico , Listeria monocytogenes/efeitos dos fármacos , Toxoplasma/efeitos dos fármacos , Estruturas Animais/microbiologia , Estruturas Animais/parasitologia , Animais , Contagem de Colônia Microbiana , Modelos Animais de Doenças , Listeriose/tratamento farmacológico , Camundongos , Testes de Sensibilidade Microbiana , Testes de Sensibilidade Parasitária , Plasmodium falciparum , Análise de Sobrevida , Toxoplasmose Animal/tratamento farmacológico , Falha de Tratamento
2.
Mol Microbiol ; 82(5): 1204-16, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22059956

RESUMO

Toxoplasma gondii is an obligate intracellular parasite of all warm-blooded animals. We previously described a forward genetic screen to identify T. gondii mutants defective in the establishment of a chronic infection. One of the mutants isolated was disrupted in the 3' untranslated region (3'UTR) of an orthologue of bacterial translation elongation factor G (EFG). The mutant does not have a growth defect in tissue culture. Genetic complementation of this mutant with the genomic locus of TgEFG restores virulence in an acute infection mouse model. Epitope tagged TgEFG localized to the apicoplast, via a non-canonical targeting signal, where it functions as an elongation factor for translation in the apicoplast. Comparisons of TgEFG expression constructs with wild-type or mutant 3'UTRs showed that a wild-type 3'UTR is necessary for translation of TgEFG. In tissue culture, the TgEFG transcript is equally abundant in wild-type and mutant parasites; however, during an animal infection, the TgEFG transcript is increased more than threefold in the mutant. These results highlight that in tissue culture, translation in the apicoplast can be diminished, but during an animal infection, translation in the apicoplast must be fully functional.


Assuntos
Regulação Bacteriana da Expressão Gênica , Organelas/metabolismo , Biossíntese de Proteínas , Toxoplasma/patogenicidade , Toxoplasmose Animal/microbiologia , Animais , Deleção de Genes , Teste de Complementação Genética , Camundongos , Camundongos Endogâmicos CBA , Fator G para Elongação de Peptídeos/genética , Análise de Sobrevida , Toxoplasma/crescimento & desenvolvimento , Toxoplasma/metabolismo , Virulência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...